Skip to main content
. 2017 Mar 30;8:356. doi: 10.3389/fimmu.2017.00356

Table 1.

The alteration of Th subset cells in OA.

T cells Cytokines produced by T cells Alterations in the OA Reference
Th1 cells IL-2, IFN-γ, TNF-α Peripheral blood No (45, 46)
Synovial fluid Increase (30, 31, 35)
Synovial membrane Increase (15, 38, 40, 49, 50)
Th2 cells IL-4, IL-5, IL-10, IL-13 Peripheral blood No (30)
Synovial fluid No (30, 35, 48)
Synovial membrane No (38)
Th9 cells IL-9 Peripheral blood Increase (47, 58)
Synovial fluid Increase (58)
Synovial membrane
Th17 cells IL-17A, IL-17F, IL-21, IL-22 Peripheral blood No (45, 46)
Increase (47, 68)
Synovial fluid Increase (31, 70)
Synovial membrane Increase (40, 69)
Th22 cells IL-22 Peripheral blood No (45, 46)
Synovial fluid
Synovial membrane
Treg cells IL-10, TGF-β Peripheral blood Decrease (11, 68, 78)
Synovial fluid
Synovial membrane
Follicular Helper T cells CXCR5, PD-1, CD40L, Bcl-6, IL-21 Peripheral blood Increase (83)
Synovial fluid
Synovial membrane No (82)
Cytotoxic T cells Peripheral blood Decrease (84)
Noa (85)
Synovial fluid Noa (85)
Synovial membrane Increase (15, 35, 39, 86)

IL, interleukin; IFN, interferon; TNF, tumor necrosis factor; TGF, transform growth factor; CXCR5, C-X-C chemokine receptor type 5; PD-1, programmed death 1; –, further investigations are needed; OA, osteoarthritis; Th, T helper; Treg, regulatory T.

aCD8+CD45RA+, CD8+CD29+, and CD8+S6F1+ cells.